225 related articles for article (PubMed ID: 28007576)
1. Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans.
Scarpignato C; Dolak W; Lanas A; Matzneller P; Renzulli C; Grimaldi M; Zeitlinger M; Bjarnason I
Gastroenterology; 2017 Apr; 152(5):980-982.e3. PubMed ID: 28007576
[TBL] [Abstract][Full Text] [Related]
2. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy.
Fujimori S; Seo T; Gudis K; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
Gastrointest Endosc; 2009 Jun; 69(7):1339-46. PubMed ID: 19243767
[TBL] [Abstract][Full Text] [Related]
3. Muscovite is protective against non-steroidal anti-inflammatory drug-induced small bowel injury.
Huang C; Lu B; Fan YH; Zhang L; Jiang N; Zhang S; Meng LN
World J Gastroenterol; 2014 Aug; 20(31):11012-8. PubMed ID: 25152605
[TBL] [Abstract][Full Text] [Related]
4. Distribution of small intestinal mucosal injuries as a result of NSAID administration.
Fujimori S; Gudis K; Takahashi Y; Seo T; Yamada Y; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
Eur J Clin Invest; 2010 Jun; 40(6):504-10. PubMed ID: 20412292
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-Inflammatory Drug-Induced Small Bowel Injury: A Randomized, Placebo-Controlled Trial.
Washio E; Esaki M; Maehata Y; Miyazaki M; Kobayashi H; Ishikawa H; Kitazono T; Matsumoto T
Clin Gastroenterol Hepatol; 2016 Jun; 14(6):809-815.e1. PubMed ID: 26538205
[TBL] [Abstract][Full Text] [Related]
6. Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole.
Hawkey CJ; Ell C; Simon B; Albert J; Keuchel M; McAlindon M; Fortun P; Schumann S; Bolten W; Shonde A; Hugot JL; Yu V; Arulmani U; Krammer G; Rebuli R; Toth E
Clin Gastroenterol Hepatol; 2008 May; 6(5):536-44. PubMed ID: 18242145
[TBL] [Abstract][Full Text] [Related]
7. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
Fujimori S; Takahashi Y; Gudis K; Seo T; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
J Gastroenterol; 2011 Jan; 46(1):57-64. PubMed ID: 20924615
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
Niwa Y; Nakamura M; Ohmiya N; Maeda O; Ando T; Itoh A; Hirooka Y; Goto H
J Gastroenterol; 2008; 43(4):270-6. PubMed ID: 18458842
[TBL] [Abstract][Full Text] [Related]
9. Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study.
Kuramoto T; Umegaki E; Nouda S; Narabayashi K; Kojima Y; Yoda Y; Ishida K; Kawakami K; Abe Y; Takeuchi T; Inoue T; Murano M; Tokioka S; Higuchi K
BMC Gastroenterol; 2013 May; 13():85. PubMed ID: 23672202
[TBL] [Abstract][Full Text] [Related]
10. Bifidobacteriumbreve Bif195 Protects Against Small-Intestinal Damage Caused by Acetylsalicylic Acid in Healthy Volunteers.
Mortensen B; Murphy C; O'Grady J; Lucey M; Elsafi G; Barry L; Westphal V; Wellejus A; Lukjancenko O; Eklund AC; Nielsen HB; Baker A; Damholt A; van Hylckama Vlieg JET; Shanahan F; Buckley M
Gastroenterology; 2019 Sep; 157(3):637-646.e4. PubMed ID: 31095949
[TBL] [Abstract][Full Text] [Related]
11. Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy.
Maiden L
J Gastroenterol; 2009; 44 Suppl 19():64-71. PubMed ID: 19148796
[TBL] [Abstract][Full Text] [Related]
12. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2014 Feb; 348(2):227-35. PubMed ID: 24254524
[TBL] [Abstract][Full Text] [Related]
13. Macroscopic small bowel mucosal injury caused by chronic nonsteroidal anti-inflammatory drugs (NSAID) use as assessed by capsule endoscopy.
Caunedo-Alvarez A; Gómez-Rodríguez BJ; Romero-Vázquez J; Argüelles-Arias F; Romero-Castro R; García-Montes JM; Pellicer-Bautista FJ; Herrerías-Gutiérrez JM
Rev Esp Enferm Dig; 2010 Feb; 102(2):80-5. PubMed ID: 20361843
[TBL] [Abstract][Full Text] [Related]
14. Visible small-intestinal mucosal injury in chronic NSAID users.
Graham DY; Opekun AR; Willingham FF; Qureshi WA
Clin Gastroenterol Hepatol; 2005 Jan; 3(1):55-9. PubMed ID: 15645405
[TBL] [Abstract][Full Text] [Related]
15. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy.
Maiden L; Thjodleifsson B; Theodors A; Gonzalez J; Bjarnason I
Gastroenterology; 2005 May; 128(5):1172-8. PubMed ID: 15887101
[TBL] [Abstract][Full Text] [Related]
16. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo.
Goldstein JL; Eisen GM; Lewis B; Gralnek IM; Zlotnick S; Fort JG;
Clin Gastroenterol Hepatol; 2005 Feb; 3(2):133-41. PubMed ID: 15704047
[TBL] [Abstract][Full Text] [Related]
17. The effects of omeprazole on healing and appearance of small gastric and duodenal lesions during dosing with diclofenac in healthy subjects.
Dorta G; Nicolet M; Vouillamoz D; Margalith D; Saraga E; Bouzourene H; Häcki WH; Stolte M; Blum AL; Armstrong D
Aliment Pharmacol Ther; 2000 May; 14(5):535-41. PubMed ID: 10792115
[TBL] [Abstract][Full Text] [Related]
18. Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease.
Prantera C; Lochs H; Grimaldi M; Danese S; Scribano ML; Gionchetti P;
Gastroenterology; 2012 Mar; 142(3):473-481.e4. PubMed ID: 22155172
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors are not the key for therapying non-steroidal anti-inflammatory drugs-induced small intestinal injury.
Zhang S; Chao GQ; Lu B
Rheumatol Int; 2013 Oct; 33(10):2513-21. PubMed ID: 23604681
[TBL] [Abstract][Full Text] [Related]
20. Geranylgeranylacetone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: a prospective randomized placebo-controlled double-blind cross-over study.
Niwa Y; Nakamura M; Miyahara R; Ohmiya N; Watanabe O; Ando T; Kawashima H; Itoh A; Hirooka Y; Goto H
Digestion; 2009; 80(4):260-6. PubMed ID: 19844108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
